Can doxepin be used in a patient with a cardiac resynchronization therapy (CRT) device?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Doxepin Be Used in Patients with CRT Devices?

Yes, doxepin can be used in patients with CRT devices, but it requires careful cardiovascular monitoring due to its cardiac effects including conduction slowing, orthostatic hypotension, and poor tolerability in patients with pre-existing heart disease.

Key Cardiovascular Concerns with Doxepin

The primary concern is that doxepin affects cardiac conduction and hemodynamics in ways that are particularly relevant to CRT patients:

  • Doxepin slows cardiac conduction, which could theoretically interfere with optimal biventricular pacing, though this effect may be less clinically significant in patients already dependent on device pacing 1

  • Orthostatic hypotension is a significant side effect, occurring frequently enough that 16% of patients with pre-existing heart disease discontinued doxepin due to cardiovascular effects in clinical studies 1

  • Contrary to common belief, doxepin is NOT safer than other tricyclics for the heart—it has comparable cardiovascular effects to imipramine and nortriptyline, with an overall dropout rate of 41% in patients with cardiac disease 1

CRT-Specific Considerations

CRT patients have unique vulnerabilities that make medication effects more consequential:

  • Maintaining near 100% biventricular pacing is critical for CRT efficacy, and any medication that affects AV conduction or causes arrhythmias could reduce pacing percentage 2

  • CRT patients typically have LVEF ≤35% and advanced heart failure (NYHA class II-IV), making them more susceptible to hemodynamic compromise from medications 2

  • Doxepin demonstrated antiarrhythmic effects in studies, which could be beneficial, but it did not adversely affect left ventricular function in patients with pre-existing LV impairment 1

Practical Management Algorithm

If doxepin is clinically necessary:

  1. Verify baseline CRT function through device interrogation to document biventricular pacing percentage (should be >95%) 2

  2. Monitor blood pressure closely given the significant orthostatic hypotension risk, particularly in patients already on guideline-directed medical therapy including beta-blockers and ACE inhibitors 1, 2

  3. Re-interrogate the CRT device 2-4 weeks after initiating doxepin to ensure biventricular pacing percentage remains optimal and no new arrhythmias have emerged 2, 3

  4. Assess for conduction changes with ECG monitoring, though patients with complete device dependence may be less affected by conduction slowing 1

  5. Consider alternative antidepressants with fewer cardiac effects (SSRIs, SNRIs) as first-line options, reserving doxepin for cases where other agents have failed 1

Critical Caveats

  • The 41% overall dropout rate and 16% cardiovascular-related dropout rate in cardiac patients suggests doxepin is poorly tolerated in this population, making close follow-up mandatory 1

  • Patients with comorbidities still derive significant benefit from CRT, so the presence of depression requiring treatment should not preclude CRT therapy, but medication selection should be optimized 2

  • Remote monitoring capabilities of modern CRT devices can facilitate early detection of any adverse effects on pacing or arrhythmia burden 2, 3

References

1
Research

Is doxepin a safer tricyclic for the heart?

The Journal of clinical psychiatry, 1991

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Management of Palpitations in Fully Paced CRT-D Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can doxepin increase the risk of atrial fibrillation (a-fib) in patients, especially those with pre-existing heart conditions or cardiovascular disease?
Can doxepin lower blood pressure?
What is Cardiac Resynchronization Therapy (CRT)?
Does Cardiac Resynchronization Therapy-Defibrillator (CRT-D) improve cardiac output in patients with heart failure?
Can doxepin cause hypotension?
What is the appropriate management of a suspected methotrexate overdose?
Can pantoprazole be taken together with lenvatinib (Lenvima) without significant drug interaction?
Can an otherwise healthy adult without hepatic or renal impairment use hydroxyzine on an as‑needed basis for anxiety, and what is the appropriate dosing regimen?
Can an adult patient without hepatic impairment or strong CYP2D6/CYP3A4 inhibitors start aripiprazole 10 mg once daily?
Do you agree with these workup templates for geriatric psychiatric patients in assisted‑living facilities—including antipsychotic initiation and monitoring, mood‑stabilizer monitoring, antidepressant initiation, delirium evaluation, and dementia evaluation—and can you suggest any additional laboratory tests or assessments?
How should I manage a patient with mildly elevated ammonia (75 µg/dL) and early compensated liver dysfunction (INR 1.2, PT 11.9 seconds, creatinine 1.01 mg/dL, albumin 3.4 g/dL, AST 32 U/L, GGT 72 U/L)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question